Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels-Reference-Cited by-同舟云学术

Furin-cleaved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Active and Modulates Low Density Lipoprotein Receptor and Serum Cholesterol Levels

Published:2012-12 Issue:52 Volume:287 Page:43482-43491
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lipari Michael T.,Li Wei,Moran Paul,Kong-Beltran Monica,Sai Tao,Lai Joyce,Lin S. Jack,Kolumam Ganesh,Zavala-Solorio Jose,Izrael-Tomasevic Anita,Arnott David,Wang Jianyong,Peterson Andrew S.,Kirchhofer Daniel

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. PCSK9. A convertase that coordinates LDL catabolism;Horton;J. Lipid Res.,2009

2. PCSK9 as a therapeutic target of dyslipidemia;Seidah;Expert. Opin. Ther. Targets,2009

3. PCSK9 and LDL cholesterol. Unravelling the target to design the bullet;Costet;Trends Biochem. Sci.,2008

4. PCSK9. An emerging target for treatment of hypercholesterolemia;Duff;Expert. Opin. Ther. Targets,2011

5. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease;Cohen;N. Engl. J. Med.,2006

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferritin‐based disruptor nanoparticles: A novel strategy to enhance LDL cholesterol clearance via multivalent inhibition of PCSK9–LDL receptor interaction;Protein Science;2024-08-16

2. Biparatopic anti-PCSK9 antibody enhances the LDL-uptake in HepG2 cells;Scientific Reports;2024-07-03

3. Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease;Journal of Clinical Lipidology;2024-07

4. Functional Roles of Furin in Cardio-Cerebrovascular Diseases;ACS Pharmacology & Translational Science;2024-02-07

5. Dihydromyricetin promotes LDL metabolism in HepG2 cells through the PCSK9/LDLR pathway;CyTA - Journal of Food;2023-09-15